US Stock MarketDetailed Quotes
CMND Clearmind Medicine
- 1.8001
- -0.4199-18.91%
Trading Jul 16 10:44 ET
5.96MMarket Cap-459P/E (TTM)
2.1200High1.7701Low1.66MVolume2.1200Open2.2200Pre Close3.19MTurnover51.06%Turnover RatioLossP/E (Static)3.31MShares16.194052wk High1.28P/B5.86MFloat Cap0.920552wk Low--Dividend TTM3.26MShs Float183.0000Historical High--Div YieldTTM15.76%Amplitude0.9205Historical Low1.9200Avg Price1Lot Size
Clearmind Medicine Key Stats
Quarterly+Annual
YOY
| (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -21.29%1.3M | -24.50%1.38M | -0.77%4.56M | 65.70%1.09M | -20.16%832.01K | -3.49%1.66M | 12.22%1.83M | 111.36%4.59M | -38.61%660.13K | 20.10%1.04M |
| Selling and administrative expenses | -26.74%980.55K | -7.14%1.16M | 49.79%3.41M | 410.92%832.22K | -20.01%632.88K | 63.42%1.34M | -4.27%1.25M | 27.37%2.28M | -136.30%-267.67K | -3.73%791.16K |
| -General and administrative expense | -26.74%980.55K | -7.14%1.16M | 49.79%3.41M | 410.92%832.22K | -20.01%632.88K | 63.42%1.34M | -4.27%1.25M | 27.37%2.28M | -136.30%-267.67K | -3.73%791.16K |
| Research and development costs | 1.70%322.96K | -61.29%227.48K | -50.68%1.12M | -73.27%234.61K | -20.66%199.13K | -64.59%317.57K | 76.75%587.63K | 492.34%2.26M | 160.97%877.66K | 446.90%250.97K |
| Depreciation amortization depletion | ---- | ---- | -46.21%26.97K | ---- | ---- | ---- | ---- | 3,194.70%50.14K | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | -46.21%26.97K | ---- | ---- | ---- | ---- | 3,194.70%50.14K | ---- | ---- |
| Operating profit | 21.29%-1.3M | 24.50%-1.38M | 0.77%-4.56M | -65.70%-1.09M | 20.16%-832.01K | 3.49%-1.66M | -12.22%-1.83M | -111.36%-4.59M | 38.61%-660.13K | -20.10%-1.04M |
| Net non-operating interest income expense | 469.14%33.96K | 236.25%60.58K | 503.91%42.79K | 209.88%11.64K | 252.10%13.06K | 5.97K | 18.02K | -10.59K | -10.59K | -8.58K |
| Non-operating interest income | 469.14%33.96K | 236.25%60.58K | ---- | ---- | ---- | --5.97K | --18.02K | ---- | ---- | ---- |
| Total other finance cost | ---- | ---- | -503.91%-42.79K | ---11.64K | -252.10%-13.06K | ---- | ---- | --10.59K | ---- | --8.58K |
| Other net income (expense) | 195.45%398.09K | 293.87%157.12K | -287.48%-1.71M | -552.40%-1.71M | 507.09%380.03K | -413.31%-417.06K | -1,499.93%-81.04K | -1,610.85%-440.26K | -262.14K | -93.35K |
| Gain on sale of security | 195.45%398.09K | 293.87%157.12K | -287.48%-1.71M | -552.40%-1.71M | 507.09%380.03K | -413.31%-417.06K | -1,499.93%-81.04K | -2,121.17%-440.26K | ---262.14K | ---93.35K |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Income before tax | 57.84%-871.46K | 38.49%-1.17M | -23.33%-6.22M | -199.33%-2.79M | 61.63%-438.92K | -15.02%-2.07M | -15.72%-1.9M | -129.39%-5.04M | 15.27%-932.86K | -31.85%-1.14M |
| Income tax | 296.63%36.76K | 5,856.25%201.5K | -42.75%12.56K | -63.44%8.02K | -5K | 9.27K | 3.38K | 21.94K | 21.94K | 0 |
| Net income | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -193.29%-2.8M | 62.07%-433.92K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K | -31.85%-1.14M |
| Net income continuous Operations | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -193.29%-2.8M | 62.07%-433.92K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K | -31.85%-1.14M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -193.29%-2.8M | 62.07%-433.92K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K | -31.85%-1.14M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 56.26%-908.22K | 27.99%-1.37M | -23.04%-6.23M | -193.29%-2.8M | 62.07%-433.92K | -15.53%-2.08M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K | -31.85%-1.14M |
| Basic earnings per share | 98.32%-0.28 | 96.37%-0.9 | 73.66%-30.7892 | 77.66%-4.6109 | 93.02%-1.8106 | 59.72%-16.62 | 36.83%-24.8 | -64.35%-116.9127 | 25.93%-20.6357 | -19.79%-25.9207 |
| Diluted earnings per share | 98.32%-0.28 | 96.37%-0.9 | 73.66%-30.7892 | 77.66%-4.6109 | 93.02%-1.8106 | 59.72%-16.62 | 36.83%-24.8 | -64.35%-116.9127 | 25.93%-20.6357 | -19.79%-25.9207 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
